# Phase 2 Sleep Initiation and: 25 recruiting (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 25 trials in phase 2 for Sleep Initiation and Maintenance Disorders that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 Sleep Initiation and Maintenance Disorders trials: 25 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/sleep-initiation-and-maintenance-disorders

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 25
- Recruiting or not yet: 25
- Read on: November 19, 2026

## Trials

The 25 newest of 25, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 5, 2026 | NCT07920185 | A Study of Oral SOM001 as a Safe and Effective Treatment for Adults With Chronic Insomnia | Somnum Pharma Inc. | Phase 2 | Not yet recruiting | Chronic Insomnia | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920185) |
| October 29, 2026 | NCT07903051 | Lemborexant on Perioperative Sleep Quality in Patients With Brain Tumor Undergoing Surgery | Beijing Tiantan Hospital | Phase 2 | Not yet recruiting | Brain Neoplasms, Sleep Initiation and Maintenance Disorders | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903051) |
| October 29, 2026 | NCT07903038 | Lemborexant on Perioperative Sleep Quality in Patients With Parkinson's Disease Undergoing Deep Brain Stimulation | Beijing Tiantan Hospital | Phase 2 | Not yet recruiting | Parkinson Disease (PD), Sleep Initiation and Maintenance Disorders, Deep Brain Stimulation | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903038) |
| July 14, 2026 | NCT07701928 | Daridorexant for People With Insomnia and Alcohol Use Disorder Study | Sponsor not shown (see the record) | Phase 2 | Not yet recruiting | Alcohol Use Disorder, Insomnia | 205 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07701928) |
| May 6, 2026 | NCT07570472 | The Effect of CBD on Sleep Quality Following Late Evening Exercise | KU Leuven | Phase 2 | Recruiting | Sleep Quality | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07570472) |
| May 4, 2026 | NCT07565974 | THC Versus THC/CBD Versus Placebo to Improve Sleep Quality for Patients With Solid Organ Cancer and Insomnia | Mayo Clinic | Phase 2 | Not yet recruiting | Insomnia, Malignant Solid Neoplasm | 69 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07565974) |
| April 1, 2026 | NCT07504536 | Ning Shen Dan Xiang Gao Fang for Heart-Kidney Disharmony Insomnia | Shanghai 7th People's Hospital | Phase 2 | Not yet recruiting | Insomnia | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07504536) |
| February 19, 2026 | NCT07420816 | Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder | Apsen Farmaceutica S.A. | Phase 2 | Recruiting | Insomnia, Insomnia Chronic | 222 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07420816) |
| February 6, 2026 | NCT07392177 | Understanding the Role of the Locus Coeruleus in Insomnia | Woolcock Institute of Medical Research | Phase 2 | Recruiting | Insomnia | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07392177) |
| January 5, 2026 | NCT07316153 | Deep Sleep in Older Adults | Proactive Life Inc | Phase 2 | Recruiting | Insomnia, Insomnia Chronic | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07316153) |
| December 23, 2025 | NCT07298941 | Resilience Enhancement Following Sleep Treatment | University of Virginia | Phase 2 | Recruiting | Chronic Low Back Pain (CLBP), Insomnia | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07298941) |
| May 21, 2025 | NCT06983080 | Efficacy of Trazodone to Treat Insomnia in Older Adults (TRADITION Study) | Centre hospitalier de l'Université de Montréal (CHUM) | Phase 2 | Recruiting | Insomnia Chronic, Older People, Drug Therapy | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06983080) |
| May 20, 2025 | NCT06981195 | Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects | Virginia Commonwealth University | Phase 2 | Recruiting | Opioid Use Disorder, Opioid Use, Insomnia, Orexin Antagonist | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06981195) |
| February 12, 2025 | NCT06823752 | A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia. | Woolcock Institute of Medical Research | Phase 2 | Recruiting | Insomnia | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06823752) |
| November 7, 2024 | NCT06679062 | Suvorexant for Treatment of AUD and PTSD | Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | Phase 2 | Recruiting | Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD), Insomnia | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06679062) |
| October 18, 2024 | NCT06648681 | Lemborexant to Prevent Post-operative Delirium in Cardiac Surgery Patients | University of British Columbia | Phase 2 | Not yet recruiting | Delirium - Postoperative, Cardiac Surgery, Cardiac Surgery Subjects, Orexin Antagonist, Feasibility Studies, Sleep... | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06648681) |
| September 24, 2024 | NCT06609369 | Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse | Yale University | Phase 2 | Recruiting | Tobacco Use, Tobacco Cessation, Insomnia | 114 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06609369) |
| July 19, 2024 | NCT06511011 | Chinese Medicine in Treating Insomnia | Chinese University of Hong Kong | Phase 2 | Recruiting | Insomnia Chronic | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06511011) |
| May 30, 2024 | NCT06434571 | Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection | University of Kansas Medical Center | Phase 2 | Recruiting | Multiple Sclerosis, Insomnia | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06434571) |
| May 28, 2024 | NCT06430333 | Sleep to Reduce Incident Depression Effectively in Peripartum | Henry Ford Health System | Phase 2 | Recruiting | Insomnia, Depression | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06430333) |
| October 4, 2022 | NCT05565833 | Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND) | University of Virginia | Phase 2 | Recruiting | Insomnia, Cognitive Dysfunction, Mild Cognitive Impairment, Sleep Initiation and Maintenance Disorders, Sleep... | 144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05565833) |
| July 1, 2022 | NCT05441280 | Pimavanserin for Insomnia in Veterans With PTSD | VA Office of Research and Development | Phase 2 | Recruiting | Post-traumatic Stress Disorder, Insomnia | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05441280) |
| November 16, 2020 | NCT04629547 | Sleep Trial to Prevent Alzheimer's Disease | University of Minnesota | Phase 2 | Recruiting | Sleep, Alzheimer Disease | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04629547) |
| June 17, 2020 | NCT04436081 | Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease | Eastern Virginia Medical School | Phase 2 | Recruiting | Alzheimer Disease, Dementia, Major Neurocognitive Disorder With Aggressive Behavior | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04436081) |
| May 20, 2020 | NCT04396327 | SM-1 vs. an Active Comparator in A Model of Transient Insomnia | Sequential Medicine Ltd | Phase 2 | Not yet recruiting | Transient Insomnia | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04396327) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Beijing Tiantan Hospital | 2 |
| University of Virginia | 2 |
| Woolcock Institute of Medical Research | 2 |
| KU Leuven | 1 |
| University of British Columbia | 1 |
| VA Office of Research and Development | 1 |
| University of Kansas Medical Center | 1 |
| Henry Ford Health System | 1 |
| Virginia Commonwealth University | 1 |
| Somnum Pharma Inc. | 1 |
| Shanghai 7th People's Hospital | 1 |
| Mayo Clinic | 1 |
| University of Minnesota | 1 |
| Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | 1 |
| Yale University | 1 |
| Proactive Life Inc | 1 |
| Apsen Farmaceutica S.A. | 1 |
| Eastern Virginia Medical School | 1 |
| Chinese University of Hong Kong | 1 |
| Sequential Medicine Ltd | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 15 |
| Canada | 2 |
| Australia | 2 |
| Belgium | 1 |
| China | 1 |
| Brazil | 1 |
| Hong Kong | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Vocational and technical schools in the United States](https://specstream.ai/data/businesses/vocational-and-technical-schools/united-states)
- [Scale suppliers in the United States](https://specstream.ai/data/businesses/scale-suppliers/united-states)
- [Orthotics providers in the United States](https://specstream.ai/data/businesses/orthotics-providers/united-states)
- [Inventory control companies in the United States](https://specstream.ai/data/businesses/inventory-control-companies/united-states)
- [Fast food restaurants in the United States](https://specstream.ai/data/businesses/fast-food-restaurants/united-states)
- [Coffee shops in the United States](https://specstream.ai/data/businesses/coffee-shops/united-states)
